Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI.

Molecular genetics and metabolism - 1 Aug 2007

Auclair Dyane, Hopwood John J, Lemontt Jeffrey F, Chen Lin, Byers Sharon

Abstract excerpt

Degenerative joint disease (DJD) is one aspect of mucopolysaccharidosis VI (MPS VI) pathology that has proven resistant to systemic enzyme replacement therapy (ERT). In this study the effect of repeated intra-articular injections (IA INJ) of recombinant human acetylgalactosamine-4-sulfatase (rh4S...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cartilage
Share to Cats
Share to Disease Models, Animal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Joints

Share to Lysosomes

Share to Recombinant Proteins

Source

Identifiers

PMID: 17544310
DOI: 10.1016/j.ymgme.2007.04.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17544310-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Long-term intra-articular administration of recombinant human N-acetylgalactosamine-4-sulfatase in feline mucopolysaccharidosis VI.PMID 17544310Read ↗

Long-term amelioration of feline Mucopolysaccharidosis VI after AAV-mediated liver gene transfer.Semantic proximity Read ↗

Enzyme replacement therapy in a murine model of Morquio A syndromeSemantic proximity Read ↗

Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8.Semantic proximity Read ↗

Two mutations within a feline mucopolysaccharidosis type VI colony cause three different clinical phenotypes.Semantic proximity Read ↗

Methylprednisolone exhibits dose dependent chondroprotection of equine articular cartilage in a cartilage degradation model in vitro.Semantic proximity Read ↗

Molecular markers for the follow-up of enzyme-replacement therapy in mucopolysaccharidosis type VI disease.Semantic proximity Read ↗

Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy.Semantic proximity Read ↗

Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.